LPL Financial
LFCR icon

LPL Financial’s Lifecore Biomedical LFCR Stock Holding History

LPL Financial’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
207,300
-490
-0.2% -$2.47K ﹤0.01% 4357
2026
Q1 		$773K Buy
207,790
+95,000
+84% +$656K ﹤0.01% 4392
2025
Q4 		$923K Sell
112,790
-35,400
-24% -$262K ﹤0.01% 4150
2025
Q3 		$1.09M Hold
148,190
– – ﹤0.01% 3913
2025
Q2 		$1.2M Buy
148,190
+2,290
+2% +$15.4K ﹤0.01% 3581
2025
Q1 		$1.03M Buy
+145,900
New +$907K ﹤0.01% 3536
2017
Q3 		– Sell
-15,215
Closed -$226K – 2903
2017
Q2 		$226K Buy
+15,215
New +$212K ﹤0.01% 2495

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

LPL Financial's LFCR Position: Q2 2026 in Review

LPL Financial reduced its Lifecore Biomedical (LFCR) stake by 0.24% in Q2 2026, selling an estimated $2.47K and leaving 207,300 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #4357.

LPL Financial first reported a position in LFCR in Q2 2017 and has held it in 7 quarters since. The position peaked at $1.2M in Q2 2025. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • LPL Financial held 207,300 shares of Lifecore Biomedical worth $1.09M as of Q2 2026.
  • LPL Financial sold 490 Lifecore Biomedical shares in Q2 2026, an estimated $2.47K.
  • Lifecore Biomedical made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4357 holding.
  • LPL Financial first reported a position in Lifecore Biomedical in Q2 2017 and has held it in 7 quarters since.
  • LPL Financial's Lifecore Biomedical position peaked at $1.2M in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.